Takeda Pharmaceutical (TAK) News Today $13.77 +0.10 (+0.73%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 6:03 AM | americanbankingnews.comTakeda Pharmaceutical (TAK) Scheduled to Post Quarterly Earnings on WednesdayJuly 19, 2024 | barrons.comTakeda Pharmaceutical Co. Ltd.July 19, 2024 | msn.comZydus ties with Takeda to sell GERD drugJuly 19, 2024 | seekingalpha.comTakeda's AI-Powered Strategy To Optimize Operations And Accelerate Its PipelineJuly 17, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Stock Holdings Lifted by Bleakley Financial Group LLCBleakley Financial Group LLC raised its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 19.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 288,535 shares of the coJuly 17, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Shares Gap Up to $13.30Takeda Pharmaceutical (NYSE:TAK) Shares Gap Up to $13.30June 26, 2024 | businesswire.comTakeda Announces New Assignments of DirectorsJune 24, 2024 | marketbeat.comPNC Financial Services Group Inc. Has $1.02 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)PNC Financial Services Group Inc. decreased its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 78.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 71,732 shares of the compaJune 24, 2024 | businesswire.comTakeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV TherapiesJune 22, 2024 | businesswire.comTakeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune ThrombocytopeniaJune 21, 2024 | businesswire.comTakeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal CancerJune 21, 2024 | reuters.comTakeda gives Sun Pharma, Cipla rights to commercialize gastro drug in IndiaJune 19, 2024 | marketbeat.comGoldman Sachs Group Inc. Sells 547,250 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Goldman Sachs Group Inc. lessened its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 11.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,302,562 shares of the company's stock after selling 547June 18, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $12.77Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $12.77June 18, 2024 | businesswire.comTakeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual MeetingJune 17, 2024 | marketbeat.comLeo Wealth LLC Makes New $1.92 Million Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)Leo Wealth LLC purchased a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 134,328 shares of the company's stock, valued at approximaJune 17, 2024 | benzinga.comWhat's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?June 17, 2024 | businesswire.comTakeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut SyndromeJune 15, 2024 | marketbeat.comOLD Mission Capital LLC Purchases 973,935 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)OLD Mission Capital LLC increased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 1,440.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,041,526 shares of the company'sJune 14, 2024 | prnewswire.comAscentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)June 14, 2024 | businesswire.comTakeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)June 7, 2024 | globenewswire.comCeliac Disease Market and Epidemiology Analysis 2018-2034 with Detailed Profiles of Marketed and Pipeline Drugs, Including KAN-101 (Kanyos Bio) and TIMP-GLIA/TAK 101 (Takeda)June 6, 2024 | marketbeat.comCapital Research Global Investors Acquires 503,446 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Capital Research Global Investors boosted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,297,805 shares of thJune 6, 2024 | seekingalpha.comTakeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside RiskJune 3, 2024 | businesswire.comTakeda's TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to PlaceboJune 1, 2024 | marketbeat.comGold Investment Management Ltd. Makes New $994,000 Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)Gold Investment Management Ltd. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 69,664 shares of the compJune 1, 2024 | businesswire.comTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaMay 31, 2024 | businesswire.comTakeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)May 30, 2024 | marketbeat.comPNC Financial Services Group Inc. Sells 255,384 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)PNC Financial Services Group Inc. reduced its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 78.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 71,732 shares of the company's stock aftMay 29, 2024 | msn.comTakeda is planning hundreds of layoffs in MassachusettsMay 29, 2024 | finance.yahoo.comTakeda Pharmaceuticals layoff plan follows $1.87 million in Massachusetts tax incentivesMay 25, 2024 | msn.comDrug giant Takeda plans more than 640 layoffs in MassachusettsMay 20, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Brandes Investment Partners LPBrandes Investment Partners LP grew its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,651,265 shares of the cMay 20, 2024 | seekingalpha.comWeek In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion DealMay 16, 2024 | finance.yahoo.comTakeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infectionMay 14, 2024 | finance.yahoo.comScilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent DisputeMay 14, 2024 | finance.yahoo.comUpdate: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent DisputeMay 14, 2024 | businesswire.comTakeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual MeetingMay 13, 2024 | businesswire.comAC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's DiseaseMay 13, 2024 | bizjournals.comMeet the Mass. life science CEOs with the largest pay packagesMay 9, 2024 | finance.yahoo.comJapan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%May 9, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Reaches New 1-Year Low at $12.77Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $12.77May 9, 2024 | seekingalpha.comTakeda Pharmaceutical Company Limited 2023 Q4 - Results - Earnings Call PresentationMay 9, 2024 | investorplace.comTAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q4 2023May 9, 2024 | reuters.comJapan's Takeda Pharma says full-year profit slumps 56%May 8, 2024 | forbes.comA Five-Pillar Process To Develop Sales LeadersMay 8, 2024 | marketwatch.comTakeda Pharmaceutical's Fourth-Quarter Profit Expected to Have More Than Tripled -- Earnings PreviewMay 2, 2024 | marketbeat.comTakeda Pharmaceutical (TAK) Set to Announce Earnings on ThursdayTakeda Pharmaceutical (NYSE:TAK) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 1, 2024 | marketbeat.comY.D. More Investments Ltd Has $17.90 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Y.D. More Investments Ltd cut its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,254,591 shares of the company'April 30, 2024 | finance.yahoo.comBeacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address This TSLA short trade is on a nine win hot streak (Ad)Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself. But I can promise that you’ll see all the details for yourself here. TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.470.62▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼14▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SNY News Today GSK News Today MRNA News Today TEVA News Today BGNE News Today RDY News Today CTLT News Today QGEN News Today PCVX News Today SMMT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
